Search results
Order by most recent / most popular / relevance
Results: 1-9 of 9
Federal Circuit holds that party seeking declaratory judgment of non-infringement bears the burden to prove non-infringement
- Jeffer Mangels Butler & Mitchell LLP
- -
- USA
- -
- September 20 2012
The U.S. Court of Appeals for the Federal Circuit vacated and remanded a Delaware court's finding that Medtronic Inc. did not infringe Boston Scientific patents relating to cardiac rhythm therapy (CRT) devices known as implantable cardioverter defribrillators (ICDs
Motion to dismiss patent infringement complaint granted where complaint used the phrase "at least" to claim more than products identified in complaint
- Jeffer Mangels Butler & Mitchell LLP
- -
- USA
- -
- September 14 2012
The above ruling, after being delayed for a month, was finally published on September 2, 2012
Motion for judgment on the pleadings denied even though defendant contended that patent infringement claim contradicted the specification of the patent-in-suit
- Jeffer Mangels Butler & Mitchell LLP
- -
- USA
- -
- September 5 2012
Intendis, Inc. ("Intendis") and Dow Pharmaceutical Sciences, Inc. ("Dow") filed a patent infringement action against River's Edge Pharmaceuticals, LLC ("River's Edge"
When plaintiffs exit market and are no longer direct competitor of defendants stay pending reexamination is justified as plaintiffs can no longer show prejudice: Wyeth v. Abbott Laboratories
- Jeffer Mangels Butler & Mitchell LLP
- -
- USA
- -
- February 17 2012
In this patent action, Defendants filed a renewed motion to the stay the proceedings pending an inter partes reexamination of the patents-in-suit
Sanctions awarded against Teva Pharmaceuticals for continuing to press inequitable conduct defense and counterclaim after Therasense
- Jeffer Mangels Butler & Mitchell LLP
- -
- USA
- -
- October 24 2011
Pfizer filed a patent infringement action against Teva Pharmaceuticals ("Teva") over a patent that claims the use of certain chemical compounds claimed as a method to treat erectile dysfunction
Even after Therasense a defense of inequitable conduct survives summary judgment
- Jeffer Mangels Butler & Mitchell LLP
- -
- USA
- -
- August 29 2011
After the Federal Circuit's decision in Thereasense, Inc. v. Becton, Dickinson and Co., 2011 WL 2028255 (Fed. Cir. 2011), it appeared likely that it would be difficult, if not impossible, to proceed on an inequitable conduct claim
Medical method claims for detecting Down syndrome is patentable under Bilski but rendered anticipated and obvious by the prior art
- Jeffer Mangels Butler & Mitchell LLP
- -
- USA
- -
- August 24 2011
In a patent dispute over a method for detecting fetal Down syndrome, the United States District Court for the District of Massachusetts invalidated the patent owner's patent because it was anticipated and obvious
The person of ordinary skill in the art may not save your patent
- Jeffer Mangels Butler & Mitchell LLP
- -
- USA
- -
- June 8 2011
To have a valid patent, an inventor must disclose sufficient detail in the specification to enable the patent, often referred to as the enablement requirement
Are methods for medical treatments patentable? Yesas as long as they are transformative
- Jeffer Mangels Butler & Mitchell LLP
- -
- USA
- -
- May 24 2011
After the United States Supreme Court's decision in the Bilski v. Kappos case, it became unclear whether patents purporting to protect methods for medical treatment would remain valid
Current Search
- Jurisdiction - USA
- Workarea - Patents
- Workarea - Healthcare
- Author - Stanley M. Gibson